Local and systemic immune mechanisms underlying the anti-colitis effects of the dairy bacterium Lactobacillus delbrueckii

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Santos Rocha, Clarissa ^a,b   Gomes Santos, Ana Cristina ^a   Garcias Moreira, Thais ^a   De Azevedo, Marcela ^a   Diniz Luerce, Tessalia ^a   Mariadassou, Mahendra ^c   Longaray Delamare, Ana Paula ^d   Langella, Philippe ^b   Maguin, Emmanuelle ^b   Azevedo, Vasco ^a   De Faria, Ana Maria Caetano ^a   Miyoshi, Anderson ^a   Van De Guchte, Maarten ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UMR1319 MICALIS   (France)

^c INRA Institut National de la Recherche Agronomique   (France)

^d UNIVERSITY OF CAXIAS DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 6; PROBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CELL EXPANSION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; FEMALE; IMMUNOMODULATION; IN VIVO STUDY; LACTOBACILLUS DELBRUECKII; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; CD4-POSITIVE T-LYMPHOCYTES; CECUM; CELL DIFFERENTIATION; COLITIS; COLON; CYTOKINES; DAIRYING; DEXTRAN SULFATE; FEMALE; HUMANS; IMMUNOGLOBULIN A, SECRETORY; LACTOBACILLUS DELBRUECKII; LYMPH NODES; MICE; MICE, INBRED C57BL; SPLEEN;

EID: 84908192096     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085923     Document Type: Article

References (47)

1. Neish AS (2009) Microbes in gastrointestinal health and disease. Gastroenterology 136: 65-80.
2. Hooper LV, Macpherson AJ (2010) Immune adaptations that maintain homeostasis with the intestinal microbiota. Nature reviews Immunology 10: 159-169.
3. Kamada N, Seo SU, Chen GY, Nunez G (2013) Role of the gut microbiota in immunity and inflammatory disease. Nature reviews Immunology 13: 321-335.
4. Faria AM, Weiner HL (2005) Oral tolerance. Immunological reviews 206: 232-259. (Pubitemid 41105174)
5. Strober W, Fuss I, Mannon P (2007) The fundamental basis of inflammatory bowel disease. J Clin Invest 117: 514-521. (Pubitemid 46348505)
6. Bouma G, Strober W (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3: 521-533. (Pubitemid 37328672)
7. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105: 16731-16736.
8. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, et al. (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15: 1183-1189.
9. Mileti E, Matteoli G, Iliev ID, Rescigno M (2009) Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PloS one 4: e7056.
10. Meijer BJ, Dieleman LA (2011) Probiotics in the treatment of human inflammatory bowel diseases: update 2011. Journal of clinical gastroenterology 45 Suppl: S139-144.
11. Ohland CL, Macnaughton WK (2010) Probiotic bacteria and intestinal epithelial barrier function. American journal of physiology Gastrointestinal and liver physiology 298: G807-819.
12. Lievin V, Peiffer I, Hudault S, Rochat F, Brassart D, et al. (2000) Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 47: 646-652.
13. de Moreno de Leblanc A, Del Carmen S, Zurita-Turk M, Santos Rocha C, van de Guchte M, et al. (2011) Importance of IL-10 modulation by probiotic microorganisms in gastrointestinal inflammatory diseases. ISRN gastroenterology 2011: 892971.
14. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 174: 3237-3246. (Pubitemid 40354026)
15. Round JL, Mazmanian SK (2010) Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 107: 12204-12209.
16. Santos Rocha C, Lakhdari O, Blottiere HM, Blugeon S, Sokol H, et al. (2012) Anti-inflammatory properties of dairy lactobacilli. Inflamm Bowel Dis 18: 657-666.
17. Jobin C, Sartor RB (2000) The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection. American journal of physiology Cell physiology 278: C451-462. (Pubitemid 30154924)
18. Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, et al. (1993) Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 38: 1722-1734. (Pubitemid 23271431)
19. McCafferty DM, Sihota E, Muscara M, Wallace JL, Sharkey KA, et al. (2000) Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice. Am J Physiol Gastrointest Liver Physiol 279: G90-99. (Pubitemid 30612686)
20. Maron R, Hancock WW, Slavin A, Hattori M, Kuchroo V, et al. (1999) Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines. Int Immunol 11: 1573-1580. (Pubitemid 29425748)
21. Pinheiro J, Bates D (2000) Mixed-effects models in S and S-PLUS. Berlin: Springer.
22. Solomon L, Mansor S, Mallon P, Donnelly E, Hoper M, et al. (2010) The dextran sulphate sodium (DSS) model of colitis: an overview. Comp Clin Pathol 19: 235-239.
23. O'Sullivan DJ (2001) Screening of intestinal microflora for effective probiotic bacteria. J Agric Food Chem 49: 1751-1760.
24. Malin M, Suomalainen H, Saxelin M, Isolauri E (1996) Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab 40: 137-145. (Pubitemid 26335799)
25. Hamilton MJ, Sinnamon MJ, Lyng GD, Glickman JN, Wang X, et al. (2011) Essential role for mast cell tryptase in acute experimental colitis. Proc Natl Acad Sci U S A 108: 290-295.
26. Melgar S, Karlsson A, Michaelsson E (2005) Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 288: G1328-1338. (Pubitemid 40741088)
27. Thomas CM, Versalovic J (2010) Probiotics-host communication: Modulation of signaling pathways in the intestine. Gut microbes 1: 148-163.
28. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, et al. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702. (Pubitemid 20069706)
29. Laroui H, Ingersoll SA, Liu HC, Baker MT, Ayyadurai S, et al. (2012) Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon. PloS one 7: e32084.
30. Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-beta. Annu Rev Immunol 16: 137-161.
31. Fichtner-Feigl S, Fuss IJ, Young CA, Watanabe T, Geissler EK, et al. (2007) Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J Immunol 178: 5859-5870. (Pubitemid 46674383)
32. Pallone F, Monteleone G (1998) Interleukin 12 and Th1 responses in inflammatory bowel disease. Gut 43: 735-736. (Pubitemid 28539644)
33. Brand S (2009) Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 58: 1152-1167.
34. Swain SL, Weinberg AD, English M, Huston G (1990) IL-4 directs the development of Th2-like helper effectors. Journal of immunology 145: 3796-3806.
35. Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, et al. (2004) Anti-interleukin-12 antibody for active Crohn's disease. The New England journal of medicine 351: 2069-2079. (Pubitemid 39482500)
36. Chung YW, Choi JH, Oh TY, Eun CS, Han DS (2008) Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in Toll-like receptor 4 mutant mice. Clin Exp Immunol 151: 182-189. (Pubitemid 350230997)
37. Philippe D, Heupel E, Blum-Sperisen S, Riedel CU (2011) Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis. International journal of food microbiology 149: 45-49.
38. Kim SW, Kim HM, Yang KM, Kim SA, Kim SK, et al. (2010) Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice. Inflamm Bowel Dis 16: 1514-1525.
39. Nishitani Y, Tanoue T, Yamada K, Ishida T, Yoshida M, et al. (2009) Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice. International immunopharmacology 9: 1444-1451.
40. Diaz-Ropero MP, Martin R, Sierra S, Lara-Villoslada F, Rodriguez JM, et al. (2007) Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response. Journal of applied microbiology 102: 337-343. (Pubitemid 46114999)
41. Lavasani S, Dzhambazov B, Nouri M, Fak F, Buske S, et al. (2010) A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PloS one 5: e9009.
42. Curotto de Lafaille MA, Lafaille JJ (2009) Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30: 626-635.
43. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4 +CD25+ regulatory T cells. Nat Immunol 4: 330-336. (Pubitemid 36432314)
44. Makita S, Kanai T, Oshima S, Uraushihara K, Totsuka T, et al. (2004) CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells.J Immunol 173: 3119-3130. (Pubitemid 39142018)
45. Maul J, Loddenkemper C, Mundt P, Berg E, Giese T, et al. (2005) Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 128: 1868-1878. (Pubitemid 40824698)
46. Macho Fernandez E, Valenti V, Rockel C, Hermann C, Pot B, et al. (2011) Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 60: 1050-1059.
47. Smelt MJ, de Haan BJ, Bron PA, van Swam I, Meijerink M, et al. (2012) L. plantarum, L. salivarius, and L. lactis attenuate Th2 responses and increase Treg frequencies in healthy mice in a strain dependent manner. PLoS One 7: e47244.